Mpox Vaccines
The U.S. national Mpox vaccine strategy was announced on June 28, 2022, and updated vaccination schedules for the 2022 Outbreak were published on August 22, 2022. The U.S. Food and Drug Administration (FDA) issued Approval for the Jynneos® (MVA-BN, IMVANEX®, IMVAMUNE®) Smallpox and Mpox Vaccine, Live, Non-Replicating, for the prevention of disease in adults determined to be at high risk for smallpox or mpox infection on September 24, 2019. Jynneos…
#monkeypox #monkeypoxtravel